药物监督药物开发中的尽职调查:风险识别,合规性评估和战略决策的实用手册
Ashraf Youssef1, Tarek A Hammad2
1Medical Safety of Marketed Products, Patient Safety and Pharmacovigilance, Takeda Development Centre Americas, Inc., Cambridge, MA, USA. hgpublications@gmail.com.
Drug safety
|December 16, 2025
概括
药物监督 (PV) 专家通过评估产品安全,在药品尽职调查 (DD) 中发挥关键作用. 这种系统的方法有助于预测利益风险概况,并识别潜在的安全障碍,以便做出明智的决策.
科学领域:
- 制药科学 制药科学
- 监管事务 监管事务
- 药品安全 药品安全
背景情况:
- 尽职调查 (DD) 对于制药的许可和收购至关重要.
- 安全评估对于监管批准和市场准入至关重要.
- 药监督 (PV) 专业知识对于在DD期间评估产品安全至关重要.
研究的目的:
- 定义PV和安全专家在制药DD中的作用.
- 概述DD中的关键安全问题和潜在的红旗.
- 为评估安全数据包提供一个结构化的方法.
主要方法:
- 专注于DD过程中的安全评估.
- 确定与安全相关的关键问题和潜在风险.
- 开发一个系统的方法,并制定一个游戏手册和检查清单.
主要成果:
- 关键的安全考虑包括器官毒性,标签责任和风险管理.
- 预测利益风险概况和确定批准障碍至关重要.
- 结构化方法有助于主动和风险校准的决策.
结论:
- 光伏专家是评估药品科学和监管可行性的重要组成部分.
- 一个系统的安全DD流程增强了交易中的决策.
- 识别与安全相关的障碍主动地减轻风险并最大限度地提高产品价值.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Control Governance: Regulatory Bodies and Their Impact
457
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
457


